SCHEMBL13673705

SCHEMBL13673705

CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCCON(O)O

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 12/20 0.80
▸ SMN1; SMN2 Q16637 3/20 0.80
▸ MAPT P10636 2/20 0.80
▸ POLB P06746 1/20 0.80
▸ GAA P10253 1/20 0.80
▸ NFKB1 P19838 2/20 0.76
▸ PMP22 Q01453 1/20 0.76
▸ TSHR P16473 1/20 0.76
▸ PGR P06401 3/20 0.74
▸ LMNA P02545 3/20 0.74
▸ SERPINA6 P08185 2/20 0.74
▸ AR P10275 2/20 0.74
▸ CHRM1 P11229 2/20 0.74
▸ CYP3A4 P08684 2/20 0.72
▸ NR3C1 P04150 3/20 0.67
▸ NR3C2 P08235 3/20 0.67
▸ CYP2C19 P33261 2/20 0.67
▸ HSD17B10 Q99714 2/20 0.67
▸ KMT2A Q03164 2/20 0.67
▸ SHBG P04278 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13181574 0.92 HIF1A (0.69) HIF1ASMN1; SMN2MAPTPOLBGAA
SCHEMBL13669679 0.91 HIF1A (0.86) HIF1ASMN1; SMN2MAPTPOLBGAA
SCHEMBL80604 0.91 HIF1A (0.95) HIF1ASMN1; SMN2MAPTPOLBGAA
SCHEMBL2679288 0.91 HIF1A (0.95) HIF1ASMN1; SMN2MAPTPOLBGAA
SCHEMBL4450347 0.91 HIF1A (0.86) HIF1ASMN1; SMN2MAPTPOLBGAA
SCHEMBL16018308 0.91 HIF1A (0.93) HIF1ASMN1; SMN2MAPTPOLBGAA
SCHEMBL13181585 0.90 HIF1A (0.72) HIF1ASMN1; SMN2MAPTPOLBGAA
SCHEMBL4450339 0.90 HIF1A (0.84) HIF1ASMN1; SMN2MAPTPOLBGAA
SCHEMBL5084679 0.90 HIF1A (0.98) HIF1ASMN1; SMN2MAPTPOLBGAA
SCHEMBL13669677 0.90 HIF1A (0.84) HIF1ASMN1; SMN2MAPTPOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605151-B2 angiogenesis inhibitor; antiinflammatory agents; immunosuppressants; steroids conjugated compound NICOX S.A. (FR) 2009-10-20 — — US disclosed
US-20080234242-A1 NITRATE ESTERS OF CORTICOID COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF NICOX S.A. (FR) 2008-09-25 — — US disclosed
US-7368442-B2 Nitrate esters of corticoid compounds and pharmaceutical applications thereof NICOX S.A. (FR) 2008-05-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234242-A1 NITRATE ESTERS OF CORTICOID COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF NR3C2, CYP11B2, NR3C1 HIF1A 2540/4885SMN1; SMN2 4089/4885MAPT 3509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback